Last reviewed · How we verify
aripiprazole, quetiapine, or risperidone
At a glance
| Generic name | aripiprazole, quetiapine, or risperidone |
|---|---|
| Also known as | Abilify, Seroquel, Risperdal |
| Sponsor | Northwell Health |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Enhancing Recovery in Early Schizophrenia (PHASE2)
- Magnetic Seizure Therapy for Psychotic Disorders (NA)
- National Pregnancy Registry for Psychiatric Medications
- Maternal And Infant Antipsychotic Study
- Measurement of Treatment Effects (EARLY_PHASE1)
- A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform (PHASE3)
- A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal
- Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- aripiprazole, quetiapine, or risperidone CI brief — competitive landscape report
- aripiprazole, quetiapine, or risperidone updates RSS · CI watch RSS
- Northwell Health portfolio CI